Bethanidine
Bethanidine (BW 467C60 (free base)) is an orally active antihypertensive agent and adrenergic neuron blocking agent. Bethanidine exerts its antihypertensive effect by inhibiting the release of norepinephrine from sympathetic nerve terminals. Bethanidine prolongs the action potential duration and the effective/functional refractory period, slows the recovery of membrane excitability after repolarization, and suppresses spontaneous action potentials induced by paired stimulation when the refractory period is sufficiently prolonged. Bethanidine shortens the duration of ventricular tachyarrhythmias and prevents electrically induced ventricular tachycardia. Bethanidine reduces metabolic rate and improves energy utilization efficiency in mice, resulting in a significant increase in body fat. Bethanidine restores tyramine-induced cardiovascular effects in Reserpine (HY-N0480)-treated anesthetized rats depleted of catecholamines. Bethanidine can be used in research on arrhythmias, inflammatory bowel disease, and primary hypertension.
For research use only. We do not sell to patients.
- CAS No.: 55-73-2
- Formula: C10H15N3
- Molecular Weight:177.25
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Adrenergic Receptor Isoforms
More
Biological Activity
Description
In Vitro
Bethanidine is predicted by molecular docking and molecular dynamics simulation to form a stable complex with SENP1 and inhibit its activity[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Bethanidine (2-20 mg/kg; intravenous bolus; administered 6 minutes before, 60 minutes before, or 1 minute after coronary artery occlusion) dose-dependently shortens the duration of ventricular tachyarrhythmias during permanent coronary artery occlusion in rats, and shortens the duration of reperfusion ventricular tachyarrhythmias in rats[1].
Bethanidine (1-5 mg/kg; i.v.) restores tyramine-induced pressor and chronotropic responses in reserpine (HY-N0480)-treated anesthetized rats, with only slight recovery of the pressor effect at 1 mg/kg and a more pronounced effect at 5 mg/kg[4].
Bethanidine (10 mg/kg; s.c.) restores the immediate tyramine pressor response in conscious Reserpine-treated rats[4].
Bethanidine (5 mg/kg; i.v.) does not further enhance the tyramine response in nialamide-pretreated reserpinized rats[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 55-73-2
-
Molecular Weight 177.25
-
Formula C10H15N3
-
SMILES
N(=C(NC)NC)CC=1C=CC=CC1
-
Synonyms
BW 467C60 free base
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Bethanidine
- 55-73-2
- BW 467C60
- Adrenergic Receptor
- Beta Receptor
- SENP1
- adrenergic neurone blocker
- catecholamine deamination
- essential hypertension
- inflammatory bowel disease
- monoamine oxidase
- norepinephrine release
- sympathetic nerve endings
- ventricular tachyarrhythmia
- ventricular tachycardia
- Inhibitor
- inhibitor
- inhibit